Literature DB >> 11343889

Controlled-release tablets from carrageenans: effect of formulation, storage and dissolution factors.

V K Gupta1, M Hariharan, T A Wheatley, J C Price.   

Abstract

The purpose of this study was to investigate the potential of two carrageenans, iota-carrageenan and lambda-carrageenan for the preparation of controlled-release tablets. Tablets were compressed on a Carver press and the effect of formulation factors, moisture, and storage on the release of theophylline was studied. The effect of sodium chloride in the tablet formulation and a change in the ionic strength of the dissolution media was studied on the release of three model drugs. The release rate increased both with an increase in tablet diameter and increase in drug to carrageenan ratio in the tablets. The two lubricants studied had a negligible effect on the rate of drug release at their commonly used concentrations. Moisture content of carrageenans, storage of tablets at 37 degrees C/75% RH for 3 months, and incorporation of 10% sodium chloride in the tablets did not have any significant effect on the release rate. The change in ionic strength of simulated gastric fluid altered the release rate whereas the ionic strength of simulated intestinal fluid did not have a significant effect on the release rate. Carrageenan tablets were relatively insensitive to small changes in formulation parameters and dissolution conditions.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11343889     DOI: 10.1016/s0939-6411(01)00135-7

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  11 in total

1.  Theoretical study of hydrogen bond interactions of fluvastatin with ι-carrageenan and λ-carrageenan.

Authors:  Anastasios G Papadopoulos; Michael P Sigalas
Journal:  J Mol Model       Date:  2010-10-28       Impact factor: 1.810

2.  Effect of oppositely charged polymer and dissolution medium on swelling, erosion, and drug release from chitosan matrices.

Authors:  Kiran S Bhise; Ravindra S Dhumal; Bhaskar Chauhan; Anant Paradkar; Shivajirao S Kadam
Journal:  AAPS PharmSciTech       Date:  2007-06-15       Impact factor: 3.246

3.  Effect of potassium chloride and cationic drug on swelling, erosion and release from kappa-carrageenan matrices.

Authors:  Syed Naim; Betty Samuel; Bhaskar Chauhan; Anant Paradkar
Journal:  AAPS PharmSciTech       Date:  2004-03-09       Impact factor: 3.246

4.  Chitosan/polyethylene glycol beads crosslinked with tripolyphosphate and glutaraldehyde for gastrointestinal drug delivery.

Authors:  Thawachinee Buranachai; Nalena Praphairaksit; Nongnuj Muangsin
Journal:  AAPS PharmSciTech       Date:  2010-07-22       Impact factor: 3.246

5.  Preparation and evaluation of chitosan/carrageenan beads for controlled release of sodium diclofenac.

Authors:  Pimwipha Piyakulawat; Nalena Praphairaksit; Nuanphun Chantarasiri; Nongnuj Muangsin
Journal:  AAPS PharmSciTech       Date:  2007-11-16       Impact factor: 3.246

6.  Formulation and evaluation of trimetazidine dihydrochloride extended release tablets by melt congealing method.

Authors:  S D Javeer; Reshma Pandit; S P Jain; Purnima Amin
Journal:  Indian J Pharm Sci       Date:  2010-11       Impact factor: 0.975

7.  Drug release kinetics and front movement in matrix tablets containing diltiazem or metoprolol/λ-carrageenan complexes.

Authors:  Ruggero Bettini; Maria Cristina Bonferoni; Paolo Colombo; Laura Zanelotti; Carla Caramella
Journal:  Biomed Res Int       Date:  2014-06-19       Impact factor: 3.411

Review 8.  Sulfated Seaweed Polysaccharides as Multifunctional Materials in Drug Delivery Applications.

Authors:  Ludmylla Cunha; Ana Grenha
Journal:  Mar Drugs       Date:  2016-02-25       Impact factor: 5.118

Review 9.  Polymeric plant-derived excipients in drug delivery.

Authors:  Carien E Beneke; Alvaro M Viljoen; Josias H Hamman
Journal:  Molecules       Date:  2009-07-16       Impact factor: 4.411

10.  The Effects of Dosage-Controlled Cannabis Capsules on Cancer-Related Cachexia and Anorexia Syndrome in Advanced Cancer Patients: Pilot Study.

Authors:  Gil Bar-Sela; Daniela Zalman; Valerya Semenysty; Eyal Ballan
Journal:  Integr Cancer Ther       Date:  2019 Jan-Dec       Impact factor: 3.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.